Coal India Q4 Results 2026 Highlights: Profit rises 11% YoY to ₹10,839 crore; Declaration of dividend of ₹5.25/share – Mint & more related News Here

Intellia Therapeutics Initiates Biologics License Application to FDA for Lonvoguran Ziclumeran (Lonvo-Z) as a One-Time Treatment for Hereditary Angioedema – Intellia Therapeutics

 & more related News Here

  1. Coal India Q4 Results 2026 Highlights: Profit rises 11% YoY to ₹10,839 crore; Dividend of ₹5.25/share declaredpeppermint
  2. Coal India Q4 results: At Rs 10,839 crore, PAT beats estimates; Maharatna PSU declares 52.5% dividendzee business
  3. Coal India Dividend Watch: How does yield compare with FD rates? Check FY26 Payment Estimates and morendtv profit
  4. Coal India’s profit rises 11% to Rs 10,839 crore in fourth quarterDeccan Herald
  5. Coal India Q4 Results, Dividend 2026 Amount Declaration Date and Time Shares rose 15% in expectation of 6 monthsbusiness today

Leave a Reply

Your email address will not be published. Required fields are marked *